Elyxyb(Celecoxib)
SCLX
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Scilex Holding Company
$1.7M
Medicare cost, 2024
$1.7M
Medicare cost, 2024
Medicare drug plans spent $1.7 million on Elyxyb (celecoxib) in 2024, for 1,462 prescriptions and refills filled by 479 patients. Spending rose 184% from 2023 to 2024. New York accounts for the most spending ($405,750, 24% of the total). It is made by Scilex Holding Company (SCLX).
Medicare cost, 2024
$1.7M
+183.7% from 2023
Prescriptions
1,462
$1,171.72 per claim
Patients
479
373 prescribers
Total spending, 2024
$1.7M
$3,576.30 per patient
Questions and answers
How much does Medicare spend on Elyxyb?
Medicare prescription drug plans paid $1.7M for Elyxyb in 2024, for 1,462 prescriptions and refills to 479 patients (up 183.7% from 2023). The average cost per claim was $1,171.72.
Which state spends the most on Elyxyb?
New York had the highest Medicare cost for Elyxyb in 2024: $406K for 419 claims, followed by Florida ($309K).
Who prescribes Elyxyb the most?
Farhad Kadkhodaei Elyaderani, neurology in Bronx, NY, had the highest Medicare cost for Elyxyb in 2024: 105 claims costing $88K.
Who makes Elyxyb?
Elyxyb is made by Scilex Holding Company (SCLX), listed in the Medicare spending data as Scilex Pharmace.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Elyxyb was $1.7M in 2024, the highest year shown.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Elyxyb, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Farhad Kadkhodaei Elyaderani Bronx, NY | Neurology | 105 | 27 | $88K |
| Josiah S Matthews IV Albany, GA | Interventional Pain Management | 12 | Under 11 | $38K |
| Wenchiang Han Marysville, CA | Neurology | 19 | Under 11 | $32K |
| Sheila Anne P Bobis Riverside, CA | Physician Assistant | 32 | Under 11 | $27K |
| Laur M Birlea Aurora, CO | Pain Management | 13 | Under 11 | $21K |
| Alicia V Cabrera Altamonte Springs, FL | Neurology | 22 | Under 11 | $19K |
| Adrian A Bunta Litchfield Park, AZ | Nurse Practitioner | 20 | Under 11 | $17K |
| Meko Y Porter Bermuda Dunes, CA | Neurology | 16 | Under 11 | $15K |
| Courtney R Chapman Amherst, NY | Nurse Practitioner | 17 | Under 11 | $15K |
| Kevin C Xie Las Vegas, NV | Neurology | 12 | Under 11 | $15K |
| Monte B Pellmar Freehold, NJ | Neurology | 13 | Under 11 | $13K |
| Rebecca S Jordan Sacramento, CA | Neurology | 15 | Under 11 | $13K |
| Arlene Carungcong-Otado Las Vegas, NV | Physician Assistant | 15 | Under 11 | $12K |
| Anatoly Shnayder Freehold, NJ | Physical Medicine and Rehabilitation | 11 | Under 11 | $12K |
| Kory Lowe Cheyenne, WY | Physician Assistant | 15 | Under 11 | $12K |
| Karly A Kozlowski Buffalo, NY | Physician Assistant | 13 | Under 11 | $12K |
| Kattalina Isakov New Hyde Park, NY | Nurse Practitioner | 14 | Under 11 | $11K |
| Anthony C Brown Fort Myers, FL | Neurology | 13 | Under 11 | $11K |
| Hui S Kang Houston, TX | Interventional Pain Management | 12 | Under 11 | $10K |
| Marina Neystat Forest Hills, NY | Neurology | 13 | Under 11 | $10K |
| Mark P Ortiz New Haven, CT | Physician Assistant | 13 | Under 11 | $10K |
| Arnaldo N Da Silva West Palm Beach, FL | Neurology | 11 | Under 11 | $10K |
| Brian A Costell Boca Raton, FL | Neurology | 11 | Under 11 | $10K |
| Esfira Shakhmurova New York, NY | Nurse Practitioner | 12 | Under 11 | $9,713 |
| Jean-Charles Gaspard Brooklyn, NY | Nurse Practitioner | 11 | Under 11 | $9,551 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 88 | 265 | 114 | $290K |
| 2023 | 180 | 531 | 226 | $604K |
| 2024 | 373 | 1,462 | 479 | $1.7M |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Scilex Pharmace | 1,462 | $1.7M |
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 132,409 side-effect reports named celecoxib, the active ingredient of Elyxyb (reports from 2003 on). 93,030 of them (70.3%) were serious, 12,746 named a death and 40,925 named a hospital stay. The reactions named most often were drug ineffective, pain and arthralgia. 29,561 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
132,409
6,704 in 2025 (+1.9% from 2024)
Serious
70.3%
93,030 reports
Deaths named
12,746
9.6% of reports
Hospital stays
40,925
30.9% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Elyxyb?
132,409 reports from 2003 through September 2026 named celecoxib, the active ingredient of Elyxyb. 93,030 of them (70.3%) were serious, 12,746 named a death and 40,925 named a hospital stay.
What are the most reported side effects of Elyxyb?
18,273 reports named drug ineffective, the reaction named most often, followed by pain (12,764) and arthralgia (11,407). In the last 5 years the reaction named most often was off label use (5,092 reports). A report can name several reactions.
How many side-effect reports named Elyxyb in 2025?
6,704 reports were received in 2025 (+1.9% from 2024). 2026 so far: 4,058 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Elyxyb caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Elyxyb caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with celecoxib: Celecoxib, Celebrex
- Makers on the stock market:
SCLX·SCLX drug pipeline - Drug approvals (18 approvals on file for celecoxib) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (celecoxib) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.